Legal Representation
Attorney
Michelle Hon Donovan
USPTO Deadlines
Next Deadline
1965 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20250527)
Due Date
May 27, 2031
Grace Period Ends
November 27, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
30 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 22, 2025 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Dec 22, 2025 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Aug 27, 2025 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Jul 11, 2025 | OPNX | P | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | Loading... |
| Jun 24, 2025 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Jun 24, 2025 | OPNR | P | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | Loading... |
| May 27, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| May 27, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Apr 8, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 8, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Apr 2, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 14, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 20, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 20, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 20, 2025 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
| Jan 22, 2025 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Jan 22, 2025 | GNSL | F | LETTER OF SUSPENSION E-MAILED | Loading... |
| Jan 22, 2025 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Jan 21, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jan 21, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 21, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Aug 17, 2024 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Jul 30, 2024 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Jul 30, 2024 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Jul 4, 2024 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Jul 3, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jul 3, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 30, 2024 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Jan 26, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 25, 2024 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Medicines for veterinary purposes, namely for treatment of metabolic diseases; animal feed additives for use as nutritional supplements; protein supplements for animals; preparations of trace elements for animal use, namely, vitamin and mineral supplements for animals; veterinary vaccines; vitamins for animals; insecticidal animal shampoos; feeding stimulants for animals; dietary supplements for animals; veterinary preparations for treatment of metabolic diseases; pharmaceuticals for treating diabetes for veterinary purposes; medicated veterinary preparations for treating skin disorders; antibiotic food supplements for animals; anaesthetics; animal feed supplements for veterinary purposes; biological preparations for veterinary purposes, namely, biological reagents for veterinary purposes; biological preparations for veterinary purposes, namely, biological tissue cultures for veterinary purposes; pharmaceutical preparations for the treatment of worms in pets; diapers for pets; medicated animal feed; medicated supplements for foodstuffs for animals; pharmaceuticals for preventing diabetes for veterinary purposes; pharmaceuticals for preventing metabolic diseases for veterinary purposes; pharmaceuticals for treating metabolic diseases for veterinary purposes
Classification
International Classes
005